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A number of distinct cell types, including dendritic cells (DC) ~  (1), macrophages 
(2),  Langerhans' cells (LC) (3),  resting or activated B cells (4), endothelial cells 
(5,  6),  and  fibroblasts  (7)  are  capable  of presenting  antigen  to  and  acting as 
accessory cells  for  the activation  of antigen-specific T  lymphocytes. Although 
these  cell  types differ  markedly  in  their  effectiveness as  APC,  they all  share 
certain common features, including the expression of MHC class II antigens, the 
ability to  process  antigen,  and  the  ability to  secrete  IL-I.  Within  the  normal 
bronchopulmonary system, only alveolar macrophages (AM) express MHC class 
II antigens (8).  Although AM  play a  central role in host defense, considerable 
controversy exists with regard to their ability to present antigen, with disparate 
results being obtained in different species (9-14). Furthermore, AM are primarily 
found in  the alveoli, and  one  would expect  the  large  areas  of mucosa of the 
tracheobronchial tree to also be sites of antigen presentation.  To evaluate this 
possibility,  we  have  examined  preparations  of human  and  mouse  bronchial 
epithelium for the presence of additional cells with antigen-presenting capability. 
Described herein are the distribution, light and electron microscopic character- 
istics, and function of a  type of bone  marrow-derived,  MHC class  II-bearing 
DC found widely within the bronchopulmonary tree as well as in the pleura.  It 
is likely that these cells play a central role in antigen presentation in the lung. 
Materials and Methods 
Human  Tissues.  Specimens  were  obtained  from  the  lower  trachea  and  mainstem 
bronchi from 15 patients during routine diagnostic bronchoscopy. The final diagnoses in 
these patients were diverse, and included bleeding of unknown cause, carcinoma, tuber- 
culosis, and idiopathic pulmonary fibrosis.  The tissues were immediately snap-frozen in 
liquid nitrogen and kept at -70°C before use. Peripheral lung tissues, including visceral 
pleura, were obtained during the course of surgery for carcinoma of the  lung.  Only 
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samples  containing normal tissue  free of carcinoma were used  for this  study.  Some of 
these samples were immediately fixed for 4 h at 4 °C in periodate-lysine-paraformaldehyde 
solution (PLP) and then washed at 4°C with PBS containing 5% sucrose for the staining 
procedures. Other samples were frozen in liquid nitrogen and stored at -70 °C until used. 
Mouse Tissues.  BALB/c mice were obtained from the Division of Research Services, 
NIH.  After exsanguination,  whole  lungs  were  excised  and  fixed  by  infusion  of PLP 
through the trachea to obtain samples with well-expanded parenchyma. The samples were 
then frozen and stored at -70°C. Tracheal epithelium was obtained as described previ- 
ously (15).  Each trachea was removed in toto; the external surface was cleaned of fat and 
connective tissue,  and the specimen was then placed in  RPMI  1640 medium. Specimens 
obtained  in  this  manner were free of contamination by peripheral  blood and al+eolar 
macrophages. The trachea was opened along the  membranous septum and cut with a 
scalpel  into sections measuring -2 ×  4  ram. These samples were immersed in a  plastic 
culture dish in 5 ml of a  20 mM EDTA solution, pH 7.4, and incubated at 37°C in an 
atmosphere with  95%  O~ and  5%  COz. After 2 h  in  EDTA, the epithelium  was lifted 
from the underlying tissue with curved forceps. The basement membrane appeared intact 
on histological analysis.  Epithelial  sheets to be stained  were washed three times  in  PBS 
containing 0.02%  sodium azide and  1%  BSA.  Tissues  for the  APC experiments  were 
washed in supplemented DMEM with  10%  FCS. The tracheal sheets were disrupted by 
gentle pipetting to obtain single-cell suspensions. 
Enriched populations of  mouse alveolar macrophages were obtained by bronchoaiveolar 
lavage with PBS. This cell population was used without further purification and contained 
90% macrophages by morphologic criteria. 
Antibodies.  The OKT6, OKT3, and OKM1  antibodies were purchased from Ortho 
Diagnostic Systems,  Raritan,  NJ.  Leu-l, Leu-2, Leu-3, FITC-conjugated anti-HLA-DR, 
d  anti-Ia , anti-Thy-l.2 FITC-conjugates and anti-IgM FITC-conjugates were from Becton 
Dickinson Monoclonal Center,  Mountain View,  CA. Anti-IgA, -IgG, -IgM, Dako pan-B, 
and Dako C3bR were from Dako Corporation, Santa Barbara,  CA. Anti-T200 T29/33 
was from Hybritech, San  Diego, CA.  Anti-Ia M5-114 (16),  anti-T200  M1/9 (17),  and 
Mac-1 M 1/70 (18) mAb were obtained from American Type Culture Collection, Rockville, 
MD. The anti-Fc-R 24G2 mAb, originally prepared by Unkeless (19), was kindly provided 
by Dr.  D. Siegal (NCI, NIH). Some of the mAb were used as FITC-conjugates in direct 
staining procedures. For indirect staining procedures, the mAb were followed either by a 
second FITC- or rhodamine-conjugated F(ab')~ goat anti-mouse IgG and IgM antibody 
(Grub Antibodies, Scandia, Vienna, Austria, or Tago, Inc., Burlingame, CA) or by FITC- 
or rhodamine-conjugated goat anti-rat IgG (Tago, Inc., or Cappel Laboratories, Coch- 
ranville,  PA).  For immunoelectron microscopy, goat F(ab')2 anti-mouse IgG conjugated 
with peroxidase (Tago, Inc.) was used as the second antibody. 
Staining Procedures.  For light microscopy, the frozen tissues (human bronchial mucosa, 
human and mouse lung) were cut with a cryostat at -20°C to a thickness of 4 ttm. After 
being air-dried on the slide, sections were fixed in cold acetone for 10 min and washed in 
PBS. The sections were incubated with the first antibody in the proper dilution in PBS- 
BSA-azide for 20 min,  washed, and  then  treated  with  the second antibody. When the 
Mac-1 and 24G2 mAb were used, a  three-step method was employed (20).  The second 
antibody  was  a  polyclonal  mouse  anti-rat  Ig (Jackson  Immunoresearch Laboratories, 
Avondale, PA), and the third antibody was a FITC- or rbodamine-conjugated goat anti- 
mouse Ig. 
tn  experiments  using double-staining,  the  second antibody  was  rhodamine-labeled. 
After being stained for the first antigen, mouse serum was applied to the sections as a 
blocking solution.  Then  FITC-conjugated anti-HLA-DR antibody or an  anti-Ia  d mAb 
conjugated toFITC was applied. 
Cell  suspensions were treated  in  the  same  way as  the  frozen sections,  but were  not 
prefixed. 
In  some  studies,  immunoperoxidase staining  with  either  the  Dako  Monoclonal  Kit 
System (Dako Corp.) in some human tissues or the Vectastain avidin-biotin system (Vector 
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For immunoelectron  microscopy, the  human  and  mouse  lung tissues  were prefixed 
with PLP and washed three times with PBS-sucrose. Frozen sections prefixed with PLP 
were cut to a thickness of 20-50 t~m. Sections were then incubated overnight at 4°C in 
the first antibody, washed, and incubated for an additional 24 h at 4°C with a peroxidase- 
labeled second antibody. The tissues were then fixed in  1.25% glutaraldehyde in PBS, 
preincubated in  0.03%  3,3'-diaminobenzidine (Sigma Chemical Co.,  St.  Louis,  MO) in 
0.05  M  Tris-HCl buffer for  30  min  at room temperature,  reacted  with  a  mixture of 
0.01% hydrogen peroxide and 0.03%  3,3'-diaminobenzidine for 10 min, postfixed with 
1% osmium tetroxide for 1 h, dehydrated in graded alcohols, and finally embedded in 
Polybed 812.  Ultrathin sections were cut and mounted on copper grids, lightly stained 
with uranyl acetate, and examined using a JEOL 100B transmission electron microscope. 
Cell suspensions from the mouse trachea were similarly processed for electron micros- 
copy after being washed with PBS-BSA-azide and then exposed to the first antibody for 
30 min and the second antibody for a final 30-min period. All of the subsequent procedures 
were done as for the tissue sections. 
Cytochemistryfor Nonspecific Esterase.  Frozen sections of human and mouse lung cut to 
a  thickness of 4  #m were fixed with cold buffered formalin for 30 s and washed with 
distilled water. These samples were incubated in a mixture of a-naphthyl acetate (N-8505; 
Sigmal Chemical Co.) and Fast Blue BB salt (F-0250; Sigma Chemical Co.) in 0.1  M Tris- 
maleate buffer, pH 7.7, in a Coplin jar at room temperature for 5 rain. After incubation, 
they  were  counterstained  with  0.1%  nuclear  fast  red  and  mounted  in  glycerin-jelly 
medium. 
Assay  for Antigen Presentation.  An OVA-specific hybridoma, A 2.2.E10, prepared from 
the draining lymph nodes of OVA-primed BALB/c mice as described previously (21), was 
used as a responder cell population. Epithelial cells and AM were washed, irradiated with 
3,000 rad, and cultured for 48 h with the responder T  cell hybridoma (105 cells) with or 
without antigen in a final volume of 0.2 ml in 96-well culture dishes. After 48 h,  100 #1 
of the culture supernatant  were removed and added to 5  ×  103  CTLL cells,  an IL-2- 
dependent T  cell line. After 24 h, the degree of stimulation of the CTLL was determined 
by measuring the incorporation of [~H]thymidine, as described previously (22). 
Treatment with Anti-Ia and C.  The epithelial cells were incubated for half an hour at 
room temperature with the rat mAb M5/114.  After being washed, a  mouse anti-rat K 
chain mAb, MAR 18.5 (23), was added to the cells as a facilitating reagent in the presence 
of nontoxic rabbit C (Cedarlane Laboratories, Hornby, Ontario, Canada) and incubated 
for 40  min at  37°C.  The C-treated  cells  were added  as accessory cells to the  culture 
described above. 
Results 
Light  Microscopy.  HLA-DR  +  (Ia  +)  DC  were  observed  in  a  rather  regular 
distribution  within  the epithelium of the  large airways of the human  lung (Fig. 
1 a). These cells were usually found either interspersed perpendicularly between 
columnar epithelial cells or just above the basal lamina with extending cytoplas- 
mic processes. The cell processes did not usually extend to the bronchial lumen. 
The population of HLA-DR  + DC represented ~ 1% of all the epithelial cells.  In 
small airways (Fig.  1 b), DC were present between the epithelial cells and appeared 
to  extend  toward  the  lumina  of the  airways.  They  were  also  detected  in  the 
vascular walls  (not  shown),  and  were  found  peripherally  as far as  the  alveolar 
septa  (Fig.  lc)  and  the  visceral  pleura  (Fig.  1 d).  DC  in  the  visceral  pleura 
exhibited  extensive  cytoplasmic processes  arranged  parallel  to  the  mesothelial 
lining.  The  DC  were  generally  very elongated,  measuring  25-40  ~m  in  total 
length  and  5-8  #m  in  width,  with  two  to  three  slender  cytoplasmic processes 
extending some distance from the cells. They did not contain vacuoles or ingested 
particles and were negative for o~-naphthyl acetate esterase, which is considered SERTL  ET  AL.  439 
FIGURE  1.  Localization of HLA-DR  + DC in normal human lung. (a) Three HLA-DR  ÷ DC 
are localized in the basal layer of epithelium in a large bronchus. Some dendrites encircle the 
basal cells and do not reach the bronchial luman (indirect immunofluorescence, x  400).  (b) 
Several HLA-DR  ÷ DC in the epithelial layer of a small bronchus. Slender cytoplasmic  processes 
extend between the epithelial cells, reaching the lumen. (c) HLA-DR  + DC in interalveolar 
septa have long cytoplasmic processes. (d) HLA-DR  ÷ DC in the visceral pleura are arranged 
in parallel with the pleural surface, and show dendrites adjacent to the alveolar epithelial cells. 
AM are also positive. (Avidin-biotin  peroxidase complex method, × 400, used for b, c, and d). 
the  most  reliable cytochemical  marker  for  macrophage  identification.  On  the 
other hand,  the AM were readily identified, appearing as large, rounded  cells in 
alveolar lumina  and  ovoid  in  the  interstitium, and  were  strongly positive when 
stained with nonspecific esterase. AM were HLA-DR + and sometimes contained 
ingested particles. 
Similar results were obtained  when  mouse  lung tissue was analyzed by immu- 
nofluorescence (Fig. 2) or immunoperoxidase  staining. The  Ia  + DC were found 
just above or beneath  the basement  membrane  in the bronchial epithelium, with 
slender, elongated cytoplasmic processes usually arranged  parallel to the surface 440  DENDRITIC  CELLS  IN  THE  LUNG 
FIGURE  2.  la  + DC in  mouse tracheal sheets. Several dendrites and cytoplasmic membrane 
are strongly positive for la (indirect immunofluorescence, x  400). 
(Fig. 3 a). The Ia  + DC in alveolar walls exhibited elongated dendrites extending 
towards  the  alveolar  iumina  (Fig.  3,  b  and  c).  DC  in  the  visceral  pleura  had 
cytoplasmic processes that extended parallel to the mesothelial lining (Fig.  3 d), 
much  as  seen  in  the  same  cells  in  the  human  lung.  In  the  cell  suspension 
preparation,  ~1% of the cells were Ia  +. 
Electron Microscopy.  Human HLA-DR  + DC in the bronchial epithelium  (Fig. 
4) and  in alveolar walls (Fig.  5a) exhibited elongated  cytoplasmic processes, a 
euchromatic  oval  nucleus,  mitochondria,  endoplasmic  reticulum,  DR  + coated 
o 
vesicles, and  80-100-A-thick  microfilaments  (Fig.  5b).  The AM had small fiio- 
podia and contained numerous iysosomes, some of which had concentric lamellae 
(Fig.  5c).  The  plasma  membranes  of the  AM  showed a  continuously  positive 
reaction to HLA-DR. No Birbeck granules were found in the mouse or human 
lung DC. 
In the murine tracheal cell suspensions, the Ia  + DC appeared as elongated cells 
(Fig. 6a), measuring ~20-30 #m in total length. Each cell had two or three thin 
dendritic processes measuring 0.1-0.6 tzm in width and ~6 #m in length, but no 
microvillous projections were apparent  on  the cell surfaces (Fig.  6b).  The  DC 
had oval, euchromatic nuclei and a rather lucent cytoplasm. While the cytoplas- 
mic  organelles  were  not  prominent,  they  had  mitochondria,  a  rather  well- 
developed Golgi apparatus  and  endoplasmic reticulum,  several coated vesicles, 
and  relatively  few microfilaments.  The  cytoplasmic processes contained  mito- 
chondria,  microfilaments, and Ia  + coated vesicles. 
To further characterize the cell surface antigens,  we used commercially avail- 
able mAb (Table I). In the human tracheal tissue, the DC were positive for HLA- 
DR and the T200 antigen, initially detected individually and later also by double 
staining (Fig. 7, a and b). These cells were negative for the OKT6 antigen, seen 
typically in LC. Double staining revealed no T  cell markers (OKT3, Leu-1, Leu- 
2,  or Leu-3) or B cell  markers  (surface Ig and pan-B from  Dako,  Inc.)  on  the 
HLA-DR  + DC. Furthermore, we detected no receptors for C3b or C3bi (OKM 1). FIGURE  3.  Localization  of  Ia  +  DC  in  the  normal  mouse  lung  (avidin-biotin  peroxidase 
complex  method, all  X  400).  (a)  la + DC  lie just above or beneath  the basal  lamina of the 
bronchus. Cytoplasmic processes extend to more than three to four basal cells. (b and c) Ia  + 
DC, as seen using bright field (b) and Nomarski differential interference contrast (c) micros- 
copy, have slender, elongated dendrites towards the alveolar lamina. (d) la  ÷ DC in the visceral 
pleura show long dendrites running parallel to the pleural surface. 
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FIGURE 4.  lmmunoelectron microscopy of HLA-DR  + cells and dendrites in the epithelium 
of a small bronchus, showing oval nucleus, HLA-DR  ÷ coated vesicles, endoplasmic reticulum, 
and short cytoplasmic processes lying over the basal cells, but no Birbeck granules (indirect 
immunoperoxidase method, x  15,000). 
The mouse DC also were positive for Ia and the T200 antigen (Fig.  8, a  and 
b). In double-staining experiments of cell suspension preparations, we found that 
DC were positive for the Fc-IgG (Fig. 8, c and d) and the C3bi receptor (Fig. 8, 
e and f). Since no staining by anti-Thy-l.2  or anti-IgM was detected, it appears 
that this cell population was not of T  or B cell origin. 
Antigen-presenting Capability of Murine Tracheal DC.  Because the Ia  + popula- 
tion present in the bronchial epithelium resembles splenic DC and the epidermal 
LC population in many respects, we compared the ability of the tracheal epithe- 
lium suspension and AM to present OVA to an OVA-specific T  cell hybridoma 
(Table lI).  Both cell populations functioned efficiently as APC.  However, since 
the tracheal epithelial population contained only 1% Ia  + cells, while  10-30% of 
the AM were Ia  +, it appeared that the epithelial DC were highly efficient APC. SERTL  ET  AL.  443 
FIGURE 5.  lmmunoelectron microscopy of HLA-DR  + cells in normal human lung (indirect 
immunoperoxidase method).  (a)  An  HLA-DR  ÷  cell  in  an  alveolar wall  shows  elongated 
cytoplasmic processes, a few positive coated vesicles, and very few lysosomes (× 5,000).  (b) A 
higher magnification view of the cytoplasm of the same cell shows HLA-DR  ÷ coated vesicles 
and endoplasmic reticulum (× 20,000).  (c) AM shows HLA-DR  ÷ plasma membrane, concentric 
lamellae and numerous lysosomes (x 8,000). 
Antigen  presentation  of AM  might  be  due  in  part  to  contaminating  DC.  To 
confirm that the only APC in the cell suspension were the Ia  ÷ DC, epithelial cells 
were treated with anti-Ia and C  or C alone, and then tested for antigen-presenting 444  DENDRITIC  CELLS  IN  THE  LUNG 
FIGURE 6.  lmmunoelectron microscopy of mouse tracheal epithelial cell suspension (indirect 
immunoperoxidase method). (a) An elongated Ia  + cell shows an oval nucleus with euchromatin, 
slender cytoplasmic processes, and la  + coated vesicles (x 6,000). (b) Higher magnification view 
of the same cell shows endoplasmic reticulum and Golgi apparatus, and la  + coated vesicles, 
but no Birbeck granules (X  15,000). 
function (Table  III). Anti-la and C  treatment  resulted in marked  diminution of 
this  function,  as  reflected  in  reduced  T  cell  activation.  This  result  strongly 
suggests that  in  the  trachea,  one role of Ia  +  DC  in the epithelial cell population 
is antigen presentation. SERTL  ET  AL. 
TABLE  I 
Phenotypic Characterization  of DC 
mAb  Human  mAb  Mouse 
HLA-DR  +  la 
T200  +  T200 
OKT6  -  Fc-lgG 
OKT3  -  Mac-I 
Leu-l, -2, -3  -  Thy-1.2 
aIgA, IgG, lgM  -  algM 
BI 
OKMI 
C3b 
mAb were used to stain sections or cell suspensions. Determinations were 
done on  15 separate patients, and each result was repeated at  least four 
times in  the mouse system. Double staining was done  on  three separate 
experiments (using HLA-DR or anti-Ia and another mAb). 
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FIGURE  7.  Two  views  of the  same  field,  showing double  immunofluorescent staining  of 
normal human bronchial  epithelium (× 400).  The epithelial  layer is at  the top;  elastic fibers 
(autofluorescent) are at  lower right, a  shows one cell  that is HLA-DR  + positive; b shows two 
T200 + cells, one of which is the same cell shown in a. 
Discussion 
We  have  shown  in  this  report  that  the  DC  population  in  both  human  and 
routine  bronchial  epithelium,  as  well as in  the aiveoli and  visceral pleura,  has 
many features in common with the DC in lymphoid organs and with epidermal 
LC. All of these populations express easily detectable MHC class II antigens (1, 
24, 25) and all appear to be bone marrow-derived, as indicated by the expression 446  DENDRITIC CELLS  IN  THE  LUNG 
FIGURE 8.  Three matched pairs of  photographs showing double immunofluorescent staining 
of mouse tracheal cell suspension (x 400). Ia antigen with T200 (a, b), la-antigen with Fc-IgG 
(c, d), and la-antigen with Mac-1 (e,f) are shown on the same cell. Some positive cytoplasmic 
staining is seen due to internalization of antibodies. 
of the T200 antigen; none of these populations show reactivity when stained for 
nonspecific esterase.  Some minor differences between the DC populations were 
noted.  In humans,  the  LC express both the  Fc-IgG-R and  the  C3b-R (26).  We 
have not yet examined human pulmonary DC for the expression of the Fc-IgG- 
R; however, we were unable to detect the C3b- or C3bi-R. The majority of the 
pulmonary DC in the mouse expressed C3bi- and Fc-IgG-R, as has been observed SERTL  ET  AL.  447 
TABLE  II 
Antigen Presentation by Murine Alveolar Macrophages and DC 
Cell number* 
[SH]Thymidine uptake* 
Alveolar macro- 
phages  Epithelial cells 
5 ×  104 (no OVA)  3,000  3,100 
5 ×  104  34,800  29,200 
3 ×  104  22,500  25,800 
104  15,100  10,000 
5 ×  10 s  ND  8,800 
l03  ND  5,900 
105 T  hybridoma cells were cultured for 48 h with the specified number 
of either alveolar macrophages or epithelial cells containing DC, with or 
without antigen. Supernatants from these cultures were assayed at a  1:2 
dilution on CTLL cells for 42 h. For the last 18 h, the cells were pulsed 
with [3H]thymidine. OVA concentration, 100 #g/ml. 
* Cell  number  reflects ~90%  alveolar  macropbages by  morphological 
criteria; 10-30% were la. Epithelial cells contained ~1% DC. 
* Mean rounded to nearest hundred. 
TABLE  III 
Ablation of Antigen-presenting  Function by Treatment with 
Anti-la and C 
OVA  [SH]Thymidine  Inhibition (%) 
Treatment  (100 #g/ml)  uptake* 
--  -  900  -- 
--  +  5,300  -- 
C  +  7,000  0 
Anti-la +  C  +  1,700  87 
3 ×  104 bronchial epithelial cells were either untreated or treated with 
MAR  18.5  and C  alone, or with anti-la, MAR  18.5,  and C, and then 
assayed as described for APC. 
* Mean rounded to nearest hundred. 
with  murine  epidermal  LC  (20),  while  splenic  DC  express  only  the  C3bi-R 
(personal  communication  from  G.  Schuler).  LC  are  the  only  DC  population 
having the typical cytoplasmic Birbeck granule.  The pulmonary  DC,  like their 
counterparts  in  lymphoid  organs  and  skin,  appear  to  be  very effective APC. 
Unfortunately,  we could perform  only a  limited  number of studies because of 
the low number of DC obtained (104  Ia + cells from 20 mouse tracheas).  Never- 
theless,  impressive  activation  of an  antigen-specific  T  cell  hybridoma  was ob- 
served.  It  will  be  important  in  future  studies  to  examine  the  accessory cell 
function of pulmonary  DC in other assays such as mitogen responses, cytotoxic 
lymphocyte induction,  and  as  stimulator  cells of the  syngeneic and  allogeneic 
MLR.  It  is conceivable that  important  differences may exist in  the  functional 
capacity  of the  different  DC  populations  in  stimulating  different  functional 
subpopulations of T  cells. Because of the low cell yield from our preparations of 
tracheas, considerable effort was made to prevent contamination of the tracheal 
cells.  Since  microscopic examination  revealed  no  erythrocytes,  monocytes,  or 
neutrophils  in the preparations,  it is unlikely that there was any contamination 448  DENDRITIC  CELLS  1N  THE  LUNG 
with peripheral blood cells. Furthermore, no AM were observed, thus excluding 
the possibility of contamination from the lower respiratory tract. A few lympho- 
cytes were present in the DC population and likely represented lymphocytes that 
are normally present within the bronchial epithelium (27). 
It is quite surprising that a DC population has never previously been described 
in bronchial epithelium.  It has been reported that no LC with typical Birbeck 
granules were apparent in normal human (28) or rat tracheal epithelium, but 
such cells have been detected in tracheal tissue in vitamin A deficiency (29), and 
in alveolar tissue in certain disease states (28). Although the expression of MHC 
class II antigens by nonlymphoid tissues has been extensively studied, bronchial 
epithelium has been described as either diffusely positive (8, 30) or completely 
negative  (31,  32).  In  tissue  samples  from  3  of our  15  patients,  anti-class  II 
reagents produced diffuse staining;  however, in  the epithelial  cells  from the 
other  12  patients,  the  test  results  were  negative.  It  is  possible  that  chronic 
environmental or microbiologic factors leads to class  II antigen expression by 
pulmonary tissues in a  manner similar to that seen in  keratinocytes in certain 
diseases (33). 
At present,  we can only speculate about  the physiologic importance of the 
pulmonary DC. As the pulmonary DC are the only MHC class II antigen-positive 
cells in  the tracheobronchial epithelium, and as they have antigen-presenting 
capability, it seems reasonable to propose that they play a  role in the afferent 
limb of the immune response, analogous to that proposed for LC in the epidermis 
(3).  Stein-Streilein has recently shown (34)  that  intratracheal,  but  not oral  or 
intravenous, application  of soluble hapten results in a  contact hypersensitivity 
response when local challenge is applied to the skin. In man, sensitization via the 
airways may also lead to subsequent acute or chronic inflammatory response in 
the bronchi and lung, or may even lead to systemic reactivity. 
The  relationship  of the  DC  in  the  periphery  of the  lung to  AM  must  be 
clarified.  In  man,  purified AM  have been  reported  to  be  devoid of antigen- 
presenting function (9), and it is possible that the main role of AM is to degrade 
foreign antigens, and thereby prevent rather than induce an immune response. 
As considerable controversy exists  in  the literature in  regard to  the antigen- 
presenting  function  in  rodent  AM  (10-14),  it  is  possible  that  such  activity 
observed in some studies was in fact mediated by contaminating DC. 
The existence of an MHC class II antigen population of pulmonary DC may 
have great importance in furthering our understanding of the immunopathology 
of rejection of lung grafts. It is likely that DC within the graft are a major source 
of the stimulating alloantigen responsible for graft rejection. Depletion of DC, 
at least in  some animal models (35),  leads to a  prolongation of graft survival. 
The  pulmonary  changes  that  occur  after  heart-lung  transplantation  include 
obliterative bronchiolitis and significant pleural fibrosis (36).  It is possible that 
donor pulmonary DC contributed to this inflammatory response. Airway obstruc- 
tion has also been reported in bone marrow transplant recipients (37), and may 
be a general manifestation of graft-vs-host disease in the lung. Again, the role of 
pulmonary DC in such a response remains to be determined. SERTL  ET  AL.  449 
Summary 
In  this  study,  we  identified  a  population  of dendritic  cells  (DC)  that  exists 
throughout human and mouse pulmonary tissues, including the trachea, bronchi, 
alveoli, and visceral pleura. In human tissue, these DC were shown to be positive 
for HLA-DR and  T200 antigens.  In the mouse,  the  DC expressed not only Ia 
and  the  T200  antigen,  but  also  Fc-IgG  and  C3bi  receptors.  Unlike  alveolar 
macrophages, the DC were negative for nonspecific esterase staining and shared 
ultrastructurai  similarities  with  the  DC  described  by  Steinman  (1),  and  with 
Langerhans' cells, even though they did not contain Birbeck granules. We were 
able to demonstrate that mouse pulmonary DC function in antigen presentation, 
as observed with the other DC. Thus, the respiratory tract contains DC that are 
capable  of functioning  in  antigen  presentation  and  that  may be  important  in 
pulmonary immune responses. 
We thank Dr. L. T6rzs6k for his assistance, Mrs. Ruth Neidhart for expert assistance with 
histology, and Karen Leighty for editorial help. 
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